Cheng‐Hui Chang
Papers
1
Total Citations
52
H-Index
1
About
Cheng-Hui Chang is a leading figure in radiation oncology physics, with a focused expertise in stereotactic body radiation therapy (SBRT) for lung cancer. His most impactful work provides a critical dosimetric comparison between robotic and conventional linear accelerator-based SBRT systems. In his landmark 2010 study, cited over 50 times, Chang retrospectively analyzed eight lung cancer patients, demonstrating that while both modalities deliver a prescribed 60 Gy, they produce distinct dose distributions. His research offers essential planning guidance for clinicians, highlighting the trade-offs in target conformity and normal tissue sparing between the two technologies. This comparative analysis has directly informed clinical decision-making, helping radiation oncologists select the optimal technique for individual patients. Chang’s contributions are foundational for practitioners seeking to maximize tumor control while minimizing pulmonary toxicity, cementing his role as a key contributor to the evidence base that shapes modern, high-precision lung cancer radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1